Clinical Trial Update: A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating QL1706 in combination with short-cycle anthracyclines or taxanes for early-stage triple-negative breast cancer, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Xijing Hospital | Conditions: TNBC, Triple Negative Breast Cancer | Phase 1 | Status: RECRUITING